EHF is a novel regulator of cellular redox metabolism and predicts patient prognosis in HNSCC

Head and Neck Squamous Cell Carcinoma (HNSCC) is a heterogeneous disease with relatively high morbidity and mortality rates. The lack of effective therapies, high recurrence rates and drug resistance driven in part, by tumor heterogeneity, contribute to the poor prognosis for patients diagnosed with...

Descripción completa

Detalles Bibliográficos
Autores principales: Oyelakin, Akinsola, Nayak, Kasturi Bala, Glathar, Alexandra Ruth, Gluck, Christian, Wrynn, Theresa, Tugores, Antonio, Romano, Rose-Anne, Sinha, Satrajit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Cancer Gene Regulation, Chromatin, and Epigenetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9155246/
https://www.ncbi.nlm.nih.gov/pubmed/35664541
http://dx.doi.org/10.1093/narcan/zcac017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9155246/
https://www.ncbi.nlm.nih.gov/pubmed/35664541
http://dx.doi.org/10.1093/narcan/zcac017

Ejemplares similares